TGen
City of Hope, TGen Debut Amplicon-Based Fragmentomic Sequencing Method for Cancer Early Detection
Premium
Investigators are planning a prospective validation this summer in adults between 65 and 75 years of age, measuring their test's ability to detect incipient cancers.
City of Hope, TGen Win $4.5M Grant to Advance Pancreatic Cancer Liquid Biopsy Screening
A City of Hope-led consortium aims to validate a noninvasive screening test for pancreatic ductal adenocarcinoma in a large-scale, diverse cohort.
Nautilus Collaborating With TGen to Study Proteins Linked to Brain Cancer
The partners will use Nautilus' protein analysis platform to study proteins associated with epigenetic changes in diffuse intrinsic pontine glioma.
Texas Research Institute, TGen, OncoHost Partner to ID Lung Cancer Resistance Mechanisms
Collaborators will study the immune profiles and molecular features of NSCLC to better understand patterns of response and resistance to immunotherapy.
In Brief This Week: Thermo Fisher Scientific, Exact Sciences, T2 Biosystems, Helix, More
News items for the week of Sept. 19, 2022.
Sep 27, 2021
Apr 26, 2021
Mar 1, 2021
Dec 9, 2020
Aug 9, 2019
Mar 15, 2019